Sign up Australia
Proactive Investors - Run By Investors For Investors

Sigma Healthcare's continued challenges further impact revenue projections

Sigma shares have fallen 3.8% to A$0.895 in the first minutes of trade.
Doctor and patient
Profits will be lower

Sigma Healthcare Ltd (ASX:SIG) shares have already been battered in the past couple of months, as the company outlined sales challenges.

Sigma closed yesterday at A$0.93, an improvement from the recent 12-month low of A$0.73, but well down from the high of A$1.53 late in 2016 before the problems were known to the market.

The company has today outlined further challenging general industry conditions.

Sigma now anticipates that 1H18 underlying EBIT will be around A$44mln, with FY2018 underlying EBIT expected to be around A$90mln.

This compares to current market consensus for FY18 of circa A$95mln underlying EBIT.

Mark Hooper, CEO and managing director, commented: "Sigma delivered above guidance growth in FY17 and remains confident that our business strategy and increased investment in infrastructure will deliver growth and efficiency improvements beyond the current year."





Register here to be notified of future . Company articles
View full . profile View Profile

Proactive Investors Australia Timeline

Related Articles

marketing
November 24 2017
Changes to the board and management team this year are having a positive effect on the performance of the business, said chief executive Steffan Williams
picture of Hunger Games cast
November 27 2017
Some of the most famous films ever made have been backed by FFI since it was founded in 1950
Laptop screen with graphs
August 04 2017
Total revenues for the six months to 30 June grew by 5%, with Ebiquity adding it remains confident in hitting its operating profits and earnings targets for the rest of the year

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use